有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Habekacin;Arbekacin;Habekacin
Chemical Name 1-N-[(S)-4-Amino-2-hydroxybutyryl]dibekacin;1-N-[(S)-4-Amino-2-hydroxybutyryl]-3,4-dideoxykanamycin B;O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1--4)-O-[2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1--6)]-N-[(2S)-4-amino-2-hydroxybutyryl]-2-deoxy-L-streptamine
CAS 51025-85-5
Related CAS 75282-65-4 (carbonate(1:2) salt)
Formula C22H44N6O10
Structure
Formula Weight 552.63018
Stage 上市-1990
Company Meiji Seika (Originator)
Activity/Mechanism Antibiotics, ANTIINFECTIVE THERAPY, Aminoglycosides
Syn. Route 5
Route 1
the acylation of 3,4-dideoxykanamycin b (dibekacin) (i) with n-benzyloxycarbonyloxysuccinimide (ii) and zinc acetate in dmso gives 3,2,6-tri-n-benzyloxycarbonydibekacin (iii), which is then treated with the n-hydroxysuccinimide ester of 2-hydroxy-4-aminobutyric acid (iv) and finally deprotected by hydrogenation with h2 over pd/c in acidic water dioxane.
List of intermediates No.
(4-chlorophenyl)methanesulfonyl chloride (i)
(ii)
(iii)
(iv)
Reference 1:
    umezawa, h.; umezawa, s.; tsuchiya, t.; takagi, y.; jikihara, t. (microbial chemistry research foundation); production of a selectively protected n-acylated derivative of an aminoglycosidic antibiotic. be 0879925; de 2945010; fr 2441631; fr 2482109; gb 2036020; gb 2065123; jp 80164696; jp 8064598; us 4297485 .
Reference 2:
    serradell, m.n.; castaner, j.; blancafort, p.; habekacin. drugs fut 1983, 8, 5, 410.

Route 2
the acylation of 3,4-dideoxykanamycin b (dibekacin) (i) with benzyloxycarbonyl chloride in water gives 6-n-benzyloxycarbonyldibekacin (v), which is then acylated with (iv) as before and deprotected by hydrogenolysis with h2 over pd/c in water - acetic acid.
List of intermediates No.
[5-[3-benzoyl-2,4-dioxo-5-vinyl-3,4-dihydro-1(2h)-pyrimidinyl]-3-(benzoyloxy)tetrahydro-2-furanyl]methyl benzoate
(4-chlorophenyl)methanesulfonyl chloride (i)
(iv)
(v)
Reference 1:
    umezawa, h.; umezawa, s.; maeda, k.; tsuchiya, o.; kondo, s.; fukatsu, s. (microbial chemistry research foundation); 1-n-[(s)-alpha-hydroxy-omega-aminoacyl]. de 2530169; fr 2201875; gb 1426908; jp 7462442; jp 7480039; jp 7494648; jp 7733629; jp 8003357; us 4001208; us 4107424 .
Reference 2:
    serradell, m.n.; castaner, j.; blancafort, p.; habekacin. drugs fut 1983, 8, 5, 410.

Route 3
the acylation of 3,2,6-tri-n-benzyloxycarbonydibekacin (iii) with ethyl trifluoroacetate and k2co3 gives 3,2,6-tri-n-benzyloxycarbonyl-3-trifluoroacetyldibekacin (vi), which is acylated again with (iv) yielding the protected habekacin (vii). finally, this compound is deprotected by hydrolysis with ammonia in aqueous thf, followed by hydrogenolysis with h2 over pd/c.
List of intermediates No.
(4-chlorophenyl)methanesulfonyl chloride (i)
(ii)
(iii)
(iv)
5-iodo-3-thiophenecarbaldehyde (vi)
(5-iodo-3-thienyl)methanol (vii)
Reference 1:
    tsuchiya, t.; takagi, y.; umezawa, s.; 1-n-acylation of aminocyclitol antibiotics via zinc chelation and regiospecific n-trifluoroacetylation. tetrahedron lett 1979, 51, 4951-54.
Reference 2:
    serradell, m.n.; castaner, j.; blancafort, p.; habekacin. drugs fut 1983, 8, 5, 410.

Route 4
the acylation of 3,4-dideoxykanamycin b (dibekacin) (i) with tert-butyl-s-(4,6-dimethylpyrimid-2-yl)thiocarbonate (viii) by means of triethylamine in isopropanol gives 3,2,6-tri-n-tert-butyloxycarbonyldibekacin (ix), which is acylated again with 4-benzyloxycarbonylamino-2-hydroxybutyric acid n-hydroxysuccinimide ester (x) in the yielding the protected habekacin (xi). finally, this compound is deprotected by a treatment with trifluoroacetic acid, followed by hydrogenolysis with h2 over pd/c in methanol - acetic acid.
List of intermediates No.
(4-chlorophenyl)methanesulfonyl chloride (i)
(viii)
(ix)
(x)
(xi)
Reference 1:
    umezawa, h.; kondo, s. (microbial chemistry research foundation); process for the preparation of 1-n-isoseryl- or 1-n-(l-4-amino-2-hydroxybutyryl)-3,4-dideoxykanamycin b and intermediates thereof. de 2950020; fr 2444046; gb 2038329; gb 2072676; gb 2072677; jp 55081897; us 4268664 .
Reference 2:
    serradell, m.n.; castaner, j.; blancafort, p.; habekacin. drugs fut 1983, 8, 5, 410.

Route 5
the acylation of 3,4-dideoxy-3,4-didehydrokanamycin b (xii) with tert-butyl-s-(4,6-dimethylpyrimid-2-yl)thiocarbonate (viii) as before gives 3,2,6-tri-n-butoxycarbonyl-3,4-dideoxy-3,4-didehydrokanamycin b (xiii), which is acylated again with (x) as before yielding the fully protected 3,4-didehydrohabekacin (xiv). partial deprotection of (xiv) with trifluoroacetic acid affords 1-n-(4-benzyloxycarbonylamino-2-hydroxybutyryl)-3,4-dideoxy-3,4-didehydrokanamycin b (xv), which is finally debenzylated and reduced by a treatment with h2 over pto2 in aqueous acetic acid.
List of intermediates No.
(viii)
(x)
(xii)
(xiii)
(5r,6s)-6-[4-(propylsulfonyl)-1,2,5-thiadiazol-3-yl]-1-azabicyclo[3.2.1]octane; 4-[(5r,6s)-1-azabicyclo[3.2.1]oct-6-yl]-1,2,5-thiadiazol-3-yl propyl sulfone (xiv)
4-[(5r,6s)-1-azabicyclo[3.2.1]oct-6-yl]-1,2,5-thiadiazole-3-thiol; 4-[(5r,6s)-1-azabicyclo[3.2.1]oct-6-yl]-1,2,5-thiadiazol-3-ylhydrosulfide (xv)
Reference 1:
    serradell, m.n.; castaner, j.; blancafort, p.; habekacin. drugs fut 1983, 8, 5, 410.

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名阿贝卡星;英文名Habekacin;Arbekacin;Habekacin;CAS[51025-85-5]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
面临涨价?6月起部分美国进口的
2018年中国植保市场畅销品牌
江苏地区顺酐市场行情整理
华北地区顺酐市场行情整理
华东地区醋酸价格
华南地区BDO市场行情僵持整理
华东地区苯酚市场稳定
华北地区BDO市场交投清淡
江苏地区二氯甲烷价格下调
华北地区醋酸价格
山东地区辛醇市场走势整理
山东地区醋酸价格
陕西地区醋酸价格
华北地区顺酐市场行情整理
华北地区顺酐市场行情整理
华北地区醋酸价格
华东地区丁二烯市场价格盘整
华东地区甲醛价格持稳
华东地区醋酸价格
华南地区正丁醇市场行情
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明